J.G. Chemicals Limited (NSE:JGCHEM)
India · Delayed Price · Currency is INR 343.45
+12.20 (3.68%)
At close: Mar 18, 2026
J.G. Chemicals Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Operating Revenue | 9,110 | 8,479 | 6,677 | 7,846 | 6,128 | 4,353 |
Other Revenue | 0.01 | 0.01 | - | - | - | - |
| 9,110 | 8,479 | 6,677 | 7,846 | 6,128 | 4,353 | |
Revenue Growth (YoY) | 13.16% | 27.00% | -14.90% | 28.02% | 40.78% | 8.99% |
Cost of Revenue | 7,507 | 6,802 | 5,521 | 6,371 | 4,991 | 3,503 |
Gross Profit | 1,603 | 1,678 | 1,156 | 1,474 | 1,137 | 850.11 |
Selling, General & Admin | 220.84 | 206.33 | 194.41 | 169.82 | 158.58 | 113.57 |
Other Operating Expenses | 582.17 | 610.01 | 507.77 | 549.54 | 425.37 | 298.07 |
Operating Expenses | 855.61 | 870.15 | 747.44 | 753.76 | 610.75 | 435.02 |
Operating Income | 747.6 | 807.43 | 408.78 | 720.71 | 526.7 | 415.09 |
Interest Expense | -2.9 | -6.22 | -33.16 | -45.47 | -59.19 | -47.84 |
Interest & Investment Income | 84.44 | 84.44 | 6.17 | 2.57 | 4.39 | 3.02 |
Currency Exchange Gain (Loss) | 29.41 | 13.99 | 43.25 | 48.53 | 42.44 | 37.88 |
Other Non Operating Income (Expenses) | -4.9 | -29.57 | 4.99 | 47.68 | 13.85 | -20.55 |
EBT Excluding Unusual Items | 853.65 | 870.07 | 430.03 | 774.02 | 528.19 | 387.6 |
Gain (Loss) on Sale of Investments | 28.23 | 28.23 | 18.95 | -8.3 | 25.97 | 24.15 |
Gain (Loss) on Sale of Assets | 0.69 | 0.69 | 0.06 | 0.13 | 1.91 | 0.23 |
Legal Settlements | - | - | -18.02 | - | - | - |
Pretax Income | 882.57 | 898.99 | 431.02 | 766.93 | 566.37 | 411.98 |
Income Tax Expense | 226.02 | 231.4 | 109.94 | 199.01 | 143.21 | 123.99 |
Earnings From Continuing Operations | 656.55 | 667.59 | 321.08 | 567.92 | 423.16 | 287.99 |
Minority Interest in Earnings | -26.44 | -27.44 | -12.52 | -18.49 | -30.75 | -53.61 |
Net Income | 630.11 | 640.15 | 308.56 | 549.43 | 392.41 | 234.38 |
Net Income to Common | 630.11 | 640.15 | 308.56 | 549.43 | 392.41 | 234.38 |
Net Income Growth | 2.03% | 107.46% | -43.84% | 40.01% | 67.42% | 80.91% |
Shares Outstanding (Basic) | 39 | 39 | 32 | 32 | 32 | 32 |
Shares Outstanding (Diluted) | 39 | 39 | 32 | 32 | 32 | 32 |
Shares Change (YoY) | 3.61% | 21.89% | 1.35% | - | - | - |
EPS (Basic) | 16.12 | 16.34 | 9.60 | 17.32 | 12.37 | 7.39 |
EPS (Diluted) | 16.12 | 16.34 | 9.60 | 17.32 | 12.37 | 7.39 |
EPS Growth | -1.52% | 70.20% | -44.58% | 40.00% | 67.42% | 81.10% |
Free Cash Flow | - | -158.87 | 665.1 | 212.79 | -22.19 | -127.26 |
Free Cash Flow Per Share | - | -4.05 | 20.69 | 6.71 | -0.70 | -4.01 |
Dividend Per Share | - | 1.000 | - | - | - | - |
Gross Margin | 17.60% | 19.78% | 17.32% | 18.79% | 18.56% | 19.53% |
Operating Margin | 8.21% | 9.52% | 6.12% | 9.19% | 8.60% | 9.54% |
Profit Margin | 6.92% | 7.55% | 4.62% | 7.00% | 6.40% | 5.38% |
Free Cash Flow Margin | - | -1.87% | 9.96% | 2.71% | -0.36% | -2.92% |
EBITDA | 807.78 | 861.18 | 453.96 | 755.03 | 553.42 | 438.39 |
EBITDA Margin | 8.87% | 10.16% | 6.80% | 9.62% | 9.03% | 10.07% |
D&A For EBITDA | 60.18 | 53.75 | 45.18 | 34.32 | 26.72 | 23.3 |
EBIT | 747.6 | 807.43 | 408.78 | 720.71 | 526.7 | 415.09 |
EBIT Margin | 8.21% | 9.52% | 6.12% | 9.19% | 8.60% | 9.54% |
Effective Tax Rate | 25.61% | 25.74% | 25.51% | 25.95% | 25.29% | 30.10% |
Revenue as Reported | 9,250 | 8,580 | 6,754 | 7,942 | 6,230 | 4,404 |
Advertising Expenses | - | 9.9 | 12.3 | 5 | 6.18 | 5.09 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.